124 related articles for article (PubMed ID: 28686970)
1. Endocytic pathways of optimized resveratrol cubosomes capturing into human hepatoma cells.
Abdel-Bar HM; El Basset Sanad RA
Biomed Pharmacother; 2017 Sep; 93():561-569. PubMed ID: 28686970
[TBL] [Abstract][Full Text] [Related]
2. Pterostilbene Nanoparticles Downregulate Hypoxia-Inducible Factors in Hepatoma Cells Under Hypoxic Conditions.
Tzeng WS; Teng WL; Huang PH; Lin TC; Yen FL; Shiue YL
Int J Nanomedicine; 2021; 16():867-879. PubMed ID: 33574667
[TBL] [Abstract][Full Text] [Related]
3. Size-dependent internalisation of folate-decorated nanoparticles via the pathways of clathrin and caveolae-mediated endocytosis in ARPE-19 cells.
Langston Suen WL; Chau Y
J Pharm Pharmacol; 2014 Apr; 66(4):564-73. PubMed ID: 24635558
[TBL] [Abstract][Full Text] [Related]
4. Intracellular trafficking and cellular uptake mechanism of mPEG-PLGA-PLL and mPEG-PLGA-PLL-Gal nanoparticles for targeted delivery to hepatomas.
Liu P; Sun Y; Wang Q; Sun Y; Li H; Duan Y
Biomaterials; 2014 Jan; 35(2):760-70. PubMed ID: 24148242
[TBL] [Abstract][Full Text] [Related]
5. Appraisal of folate functionalized bosutinib cubosomes against hepatic cancer cells: In-vitro, In-silico, and in-vivo pharmacokinetic study.
Nisha R; Kumar P; Mishra N; Maurya P; Ahmad S; Singh N; Saraf SA
Int J Pharm; 2024 Apr; 654():123975. PubMed ID: 38452833
[TBL] [Abstract][Full Text] [Related]
6. Remote Loading of Hydrophilic Drug into Cubosomes by Transmembrane pH-Gradient and Characterization of Drug-Loaded Cubosomes Prepared by Different Method.
Zeng L; Ke Y; Zheng C; Song H; Liu Z; Hu X; Zhou X
J Pharm Sci; 2023 Apr; 112(4):1119-1129. PubMed ID: 36596394
[TBL] [Abstract][Full Text] [Related]
7. A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: Preparation, cytotoxicity and intracellular uptake.
Luo Q; Lin T; Zhang CY; Zhu T; Wang L; Ji Z; Jia B; Ge T; Peng D; Chen W
Int J Pharm; 2015 Sep; 493(1-2):30-9. PubMed ID: 26209071
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting.
Ahirrao M; Shrotriya S
Drug Dev Ind Pharm; 2017 Oct; 43(10):1686-1693. PubMed ID: 28574732
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of paclitaxel-loaded nanoparticle incorporated with galactose-carrying polymer for hepatocyte targeted delivery.
Wang Y; Jiang G; Qiu T; Ding F
Drug Dev Ind Pharm; 2012 Sep; 38(9):1039-46. PubMed ID: 22124381
[TBL] [Abstract][Full Text] [Related]
10. Cubic nanoparticles as potential carriers for a natural anticancer drug: development, in vitro and in vivo characterization.
Abdou R; Mojally M; Attia HG; Dawoud M
Drug Deliv Transl Res; 2023 Oct; 13(10):2463-2474. PubMed ID: 37010791
[TBL] [Abstract][Full Text] [Related]
11. The use of surfactants to enhance the solubility and stability of the water-insoluble anticancer drug SN38 into liquid crystalline phase nanoparticles.
Ranneh AH; Iwao Y; Noguchi S; Oka T; Itai S
Int J Pharm; 2016 Dec; 515(1-2):501-505. PubMed ID: 27793711
[TBL] [Abstract][Full Text] [Related]
12. Lipidic cubic-phase leflunomide nanoparticles (cubosomes) as a potential tool for breast cancer management.
Zewail M; E Gaafar PM; Ali MM; Abbas H
Drug Deliv; 2022 Dec; 29(1):1663-1674. PubMed ID: 35616281
[TBL] [Abstract][Full Text] [Related]
13. Enhanced gene transfection efficiency in CD13-positive vascular endothelial cells with targeted poly(lactic acid)-poly(ethylene glycol) nanoparticles through caveolae-mediated endocytosis.
Liu C; Yu W; Chen Z; Zhang J; Zhang N
J Control Release; 2011 Apr; 151(2):162-75. PubMed ID: 21376765
[TBL] [Abstract][Full Text] [Related]
14. Influence of Resveratrol on Sphingolipid Metabolism in Hepatocellular Carcinoma Cells in Lipid Overload State.
Charytoniuk T; Harasim-Symbor E; Polak A; Drygalski K; Berk K; Chabowski A; Konstantynowicz-Nowicka K
Anticancer Agents Med Chem; 2019; 19(1):121-129. PubMed ID: 30585550
[TBL] [Abstract][Full Text] [Related]
15. Enhanced oral permeability of Trans-Resveratrol using nanocochleates for boosting anticancer efficacy; in-vitro and ex-vivo appraisal.
El-Melegy MG; Eltaher HM; Gaballah A; El-Kamel AH
Eur J Pharm Biopharm; 2021 Nov; 168():166-183. PubMed ID: 34481049
[TBL] [Abstract][Full Text] [Related]
16. A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment.
Bao X; Gao M; Xu H; Liu KX; Zhang CH; Jiang N; Chu QC; Guan X; Tian Y
Drug Dev Ind Pharm; 2015; 41(7):1193-203. PubMed ID: 25026246
[TBL] [Abstract][Full Text] [Related]
17. Protein-bearing cubosomes prepared by liquid precursor dilution: inner ear delivery and pharmacokinetic study following intratympanic administration.
Liu H; Wang Y; Wang Q; Li Z; Zhou Y; Zhang Y; Li S
J Biomed Nanotechnol; 2013 Oct; 9(10):1784-93. PubMed ID: 24015508
[TBL] [Abstract][Full Text] [Related]
18. Disposition and association of the steric stabilizer Pluronic® F127 in lyotropic liquid crystalline nanostructured particle dispersions.
Tilley AJ; Drummond CJ; Boyd BJ
J Colloid Interface Sci; 2013 Feb; 392():288-296. PubMed ID: 23137909
[TBL] [Abstract][Full Text] [Related]
19. A comparative assessment of antiproliferative properties of resveratrol and ethanol leaf extract of Anogeissus leiocarpus (DC) Guill and Perr against HepG2 hepatocarcinoma cells.
Olugbami JO; Damoiseaux R; France B; Onibiyo EM; Gbadegesin MA; Sharma S; Gimzewski JK; Odunola OA
BMC Complement Altern Med; 2017 Aug; 17(1):381. PubMed ID: 28768515
[TBL] [Abstract][Full Text] [Related]
20. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol.
Teskac K; Kristl J
Int J Pharm; 2010 May; 390(1):61-9. PubMed ID: 19833178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
